These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1707686)

  • 21. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies.
    Geracioti TD; Loosen PT; Ebert MH; Ekhator NN; Burns D; Nicholson WE; Orth DN
    Neuroendocrinology; 1994 Dec; 60(6):635-42. PubMed ID: 7535389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The corticotropin-releasing hormone stimulation test in chronic schizophrenia.
    Roy A; Pickar D; Doran A; Wolkowitz O; Gallucci W; Chrousos G; Gold P
    Am J Psychiatry; 1986 Nov; 143(11):1393-7. PubMed ID: 3022612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of corticotropin-releasing hormone testing in assessment of hypothalamic-pituitary-adrenal axis function in infants with congenital central hypothyroidism.
    van Tijn DA; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3794-803. PubMed ID: 18647808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
    Pasquali R; Vicennati V; Calzoni F; Gnudi U; Gambineri A; Ceroni L; Cortelli P; Menozzi R; Sinisi R; Rio GD
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder.
    Rasmusson AM; Lipschitz DS; Wang S; Hu S; Vojvoda D; Bremner JD; Southwick SM; Charney DS
    Biol Psychiatry; 2001 Dec; 50(12):965-77. PubMed ID: 11750893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function.
    Swann AC; Stokes PE; Secunda SK; Maas JW; Bowden CL; Berman N; Koslow SH
    Biol Psychiatry; 1994 May; 35(10):803-13. PubMed ID: 7519061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.
    Mastorakos G; Ilias I
    Ann N Y Acad Sci; 2003 Nov; 997():136-49. PubMed ID: 14644820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD; Loosen PT; Orth DN
    Biol Psychiatry; 1997 Aug; 42(3):165-74. PubMed ID: 9232208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dexamethasone corticotropin releasing hormone test in healthy and depressed women with and without childhood adversity.
    Spitzer C; Otte C; Kuehl LK; May A; Schultebraucks K; Hellmann-Regen J; Wingenfeld K
    Psychoneuroendocrinology; 2018 Jan; 87():147-151. PubMed ID: 29080551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
    Amsterdam JD; Maislin G; Winokur A; Kling M; Gold P
    Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.
    Melief J; de Wit SJ; van Eden CG; Teunissen C; Hamann J; Uitdehaag BM; Swaab D; Huitinga I
    Acta Neuropathol; 2013 Aug; 126(2):237-49. PubMed ID: 23812288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.